Market Overview

Fifth Third Is Worth A Premium Despite Sluggish Loan Growth, Argus Says In Bullish Initiation

Fifth Third Is Worth A Premium Despite Sluggish Loan Growth, Argus Says In Bullish Initiation

Strong fee income, a better efficiency ratio than peers and credit quality are behind Argus' bullish Fifth Third Bancorp (NASDAQ: FITB) thesis. 

The Analyst

Argus analyst Stephen Biggar initiated coverage of Fifth Third with a Buy rating and $36 price target. 

The Thesis

The bank's loan growth has been muted in recent quarters, with consumer loans and commercial/industrial loans estimated to grow 3 percent and 4 percent this year, respectively, Biggar said in the initiation note. 

Argus attributed the slow growth to a range of market conditions, including an increase in the prime lending rate; uncertainty over policy changes coming out of Washington; lower corporate taxes that have reduced the need for borrowing; and a greater preference among large corporations for direct debt placement over line-of-credit borrowing.

Higher interest rates have benefitted the net interest margin, which rose by 8 basis points in the first quarter, the analyst said. Argus projects high single-digit growth in net interest income in 2018. 

Besides two more expected rate hikes from the Fed, the biggest catalyst in Fifth Third’s future is its merger with MB Financial Inc (NASDAQ: MBFI), announced in mid-May, Biggar said. Fifth Third expects the deal to boost earnings by 7 percent in the second year after it closes.

All in all, Argus is looking for Fifth Third to trade at a premium to its regional bank peers.

Price Action

Fifth Third shares were down 0.71 percent at the time of publication Thursday morning at $30.93. 

Related Links:

Baird's Bearish Case For Fifth Third Bancorp Comes To An End After M&A Deal

Flagstar To Acquire 52 Wells Fargo Branches Across Midwest: 'It Really Is A Good Fit'

Latest Ratings for MBFI

Jan 2018DA DavidsonDowngradesBuyNeutral
Jul 2017PiperJaffrayDowngradesOverweightNeutral
Jun 2017WedbushInitiates Coverage OnNeutral

View More Analyst Ratings for MBFI
View the Latest Analyst Ratings

Posted-In: Argus Stephen BiggarAnalyst Color News Price Target Initiation Analyst Ratings Best of Benzinga


Related Articles (FITB + MBFI)

View Comments and Join the Discussion!

BMO: Aeglea Has A Potentially Market-Conquering Arginase Deficiency Candidate, Oncology Opportunity

More Central Bank News As ECB Follows Fed Rate Hike With Tapering Plans